TOX3 and breast carcinoma: In addition to the highly penetrant (BRCA1, BRCA2, and TP53) and moderately penetrant (CHEK2, BRIP1, ATM and PALB2) genetic variants, breast cancer has been associated with low penetrant risk (FGFR2, TNRC9, MAP3K1 and LSP1)11.